1. Home
  2. SAVA vs ACR Comparison

SAVA vs ACR Comparison

Compare SAVA & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAVA
  • ACR
  • Stock Information
  • Founded
  • SAVA 1998
  • ACR 2005
  • Country
  • SAVA United States
  • ACR United States
  • Employees
  • SAVA N/A
  • ACR N/A
  • Industry
  • SAVA Biotechnology: Pharmaceutical Preparations
  • ACR Real Estate Investment Trusts
  • Sector
  • SAVA Health Care
  • ACR Real Estate
  • Exchange
  • SAVA Nasdaq
  • ACR Nasdaq
  • Market Cap
  • SAVA 70.5M
  • ACR 154.7M
  • IPO Year
  • SAVA N/A
  • ACR N/A
  • Fundamental
  • Price
  • SAVA $1.76
  • ACR $18.56
  • Analyst Decision
  • SAVA Buy
  • ACR Buy
  • Analyst Count
  • SAVA 3
  • ACR 2
  • Target Price
  • SAVA $54.50
  • ACR $17.50
  • AVG Volume (30 Days)
  • SAVA 807.5K
  • ACR 32.3K
  • Earning Date
  • SAVA 05-08-2025
  • ACR 04-30-2025
  • Dividend Yield
  • SAVA N/A
  • ACR N/A
  • EPS Growth
  • SAVA N/A
  • ACR N/A
  • EPS
  • SAVA N/A
  • ACR 0.34
  • Revenue
  • SAVA N/A
  • ACR $83,545,000.00
  • Revenue This Year
  • SAVA N/A
  • ACR $8.36
  • Revenue Next Year
  • SAVA N/A
  • ACR N/A
  • P/E Ratio
  • SAVA N/A
  • ACR $55.09
  • Revenue Growth
  • SAVA N/A
  • ACR 6.92
  • 52 Week Low
  • SAVA $1.15
  • ACR $12.33
  • 52 Week High
  • SAVA $42.20
  • ACR $23.81
  • Technical
  • Relative Strength Index (RSI)
  • SAVA 54.92
  • ACR 46.21
  • Support Level
  • SAVA $1.45
  • ACR $18.30
  • Resistance Level
  • SAVA $1.67
  • ACR $19.10
  • Average True Range (ATR)
  • SAVA 0.11
  • ACR 0.74
  • MACD
  • SAVA 0.05
  • ACR 0.13
  • Stochastic Oscillator
  • SAVA 87.50
  • ACR 52.03

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: